Sam-A Pharm. Co. Ltd (009300) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.001x

Based on the latest financial reports, Sam-A Pharm. Co. Ltd (009300) has a cash flow conversion efficiency ratio of 0.001x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩162.42 Million ≈ $110.07K USD) by net assets (₩228.11 Billion ≈ $154.59 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 009300 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Sam-A Pharm. Co. Ltd - Cash Flow Conversion Efficiency Trend (2009–2025)

This chart illustrates how Sam-A Pharm. Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Sam-A Pharm. Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sam-A Pharm. Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Ariana Resources Plc AU:AA2	-0.024x
Amiad Water Systems Ltd TA:AMD	0.017x
Roscan Gold Corp V:ROS	0.162x
Gigalane Co Ltd KQ:049080	-0.089x
Eastern Platinum Limited TO:ELR	-0.033x
Kerjaya Prospek Property Bhd KLSE:7077	0.050x
Ailleron S.A. WAR:ALL	0.037x
Jakarta Int Hotels & Dev JK:JIHD	0.103x

Annual Cash Flow Conversion Efficiency for Sam-A Pharm. Co. Ltd (2009–2025)

The table below shows the annual cash flow conversion efficiency of Sam-A Pharm. Co. Ltd from 2009 to 2025. For the full company profile with market capitalisation and key ratios, see Sam-A Pharm. Co. Ltd market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩228.11 Billion ≈ $154.59 Million	₩10.72 Billion ≈ $7.27 Million	0.047x	-59.04%
2024-12-31	₩219.98 Billion ≈ $149.07 Million	₩25.25 Billion ≈ $17.11 Million	0.115x	+10.83%
2023-12-31	₩200.47 Billion ≈ $135.86 Million	₩20.76 Billion ≈ $14.07 Million	0.104x	-4.59%
2022-12-31	₩180.62 Billion ≈ $122.40 Million	₩19.60 Billion ≈ $13.29 Million	0.109x	+44.26%
2021-12-31	₩172.02 Billion ≈ $116.58 Million	₩12.94 Billion ≈ $8.77 Million	0.075x	+32.98%
2020-12-31	₩166.29 Billion ≈ $112.69 Million	₩9.41 Billion ≈ $6.38 Million	0.057x	-28.04%
2019-12-31	₩168.15 Billion ≈ $113.95 Million	₩13.22 Billion ≈ $8.96 Million	0.079x	-0.82%
2018-12-31	₩160.90 Billion ≈ $109.04 Million	₩12.76 Billion ≈ $8.64 Million	0.079x	+142.87%
2017-12-31	₩156.10 Billion ≈ $105.79 Million	₩5.10 Billion ≈ $3.45 Million	0.033x	-53.85%
2016-12-31	₩148.92 Billion ≈ $100.92 Million	₩10.53 Billion ≈ $7.14 Million	0.071x	-8.33%
2015-12-31	₩140.08 Billion ≈ $94.93 Million	₩10.81 Billion ≈ $7.32 Million	0.077x	-9.06%
2014-12-31	₩134.15 Billion ≈ $90.91 Million	₩11.38 Billion ≈ $7.71 Million	0.085x	-26.49%
2012-12-31	₩121.33 Billion ≈ $82.22 Million	₩14.00 Billion ≈ $9.49 Million	0.115x	+21.89%
2011-12-31	₩110.58 Billion ≈ $74.94 Million	₩10.47 Billion ≈ $7.10 Million	0.095x	+89.49%
2010-12-31	₩101.99 Billion ≈ $69.12 Million	₩5.10 Billion ≈ $3.45 Million	0.050x	+147.91%
2009-12-31	₩79.92 Billion ≈ $54.16 Million	₩-8.33 Billion ≈ $-5.65 Million	-0.104x	--

About Sam-A Pharm. Co. Ltd

KQ:009300 Korea Pharmaceuticals

Market Cap

$57.08 Million

₩84.23 Billion KRW

Market Cap Rank

#21460 Global

#1260 in Korea

Share Price

₩13800.00

Change (1 day)

+0.00%

52-Week Range

₩12910.00 - ₩19050.00

All Time High

₩36150.00